Cargando…
SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
The coronavirus disease 2019 pandemic has not ended, and several variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus continue to emerge. The emergence of new variants is worrying because higher transmission leads to spikes in infections, vaccine efforts, and other ther...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Vaccine Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200648/ https://www.ncbi.nlm.nih.gov/pubmed/35799876 http://dx.doi.org/10.7774/cevr.2022.11.2.173 |